The state-owned pharmaceutical firm HoldiPharma has received five offers from investment banks to manage the anticipated offerings of its subsidiaries, Chemical Industries Development (CID) and Misr Pharma, on the Egyptian Exchange (EGX).
Updated 9/18/2024 8:38:00 AM